Product Overview

Temozolomide API is a popular anti-cancer active pharmaceutical ingredient (API).

It is an alkylating agent type of drug. They are temozolomide APIs that become attached to the DNA of the cancerous cells.

This also makes it impossible for the cells to grow. Hence, the tumour growth is reduced or inhibited.

It is absorbed very easily and can penetrate through the blood–brain barrier.

This makes it extremely useful in the treatment of brain tumours, where other drugs cannot be administered.

Therapeutic Applications

Temozolomide API works well because it can reach the brain.

This makes it a strong used in formulation of oncology drugs to treat tough brain cancers.

Specification Parameters

Packaging & Storage

Temozolomide API is packed to prevent moisture and light damage. 

It is manufactured under stringent quality systems and is evaluated for purity, stability, and safety.

Double polyethylene liners in HDPE bottles or fiber drums for packing.

Pack sizes include 1 g, 10 g, 100 g, 1 kg, and bulk 25 kg drums.

Product name, CAS number, batch code, manufacture date, expiry date, and storage conditions on every container.

Keep sealed in a dry, cold place at 2–8°C. Protect from heat, light, and air.

2–3 years if stored under recommended conditions.

Tamper-evident closures assure safety in handling and shipping.

Why Choose Us

Produced under WHO-GMP and ISO-certified facilities. Each batch is assayed several times during the process by Actiza Pharmaceutical Pvt Ltd.

Drug Master Files (DMF) and Common Technical Documents (CTD) are available for filings worldwide.

Available in research-grade packaging or large commercial batches.

Supplied to leading oncology companies in the US, Europe, Asia, and Latin America.

Technical and regulatory teams help with end-to-end support on applications, compliance, and testing.